1. Home
  2. LCFY vs HKPD Comparison

LCFY vs HKPD Comparison

Compare LCFY & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Locafy Limited

LCFY

Locafy Limited

HOLD

Current Price

$4.52

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

HOLD

Current Price

$0.73

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCFY
HKPD
Founded
2009
2016
Country
Australia
Hong Kong
Employees
18
27
Industry
Other Pharmaceuticals
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
6.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LCFY
HKPD
Price
$4.52
$0.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.0K
29.3K
Earning Date
05-01-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.37
52 Week High
$13.98
$2.74

Technical Indicators

Market Signals
Indicator
LCFY
HKPD
Relative Strength Index (RSI) 51.51 55.25
Support Level $4.08 $0.63
Resistance Level $4.80 $0.70
Average True Range (ATR) 0.23 0.06
MACD -0.01 0.02
Stochastic Oscillator 59.42 74.34

Price Performance

Historical Comparison
LCFY
HKPD

About LCFY Locafy Limited

Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Share on Social Networks: